Journal
VACCINE
Volume 30, Issue 30, Pages 4409-4413Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2012.04.090
Keywords
Carbohydrate moieties; Vaccine; Glycans; Immune response; Glycomics; Adjuvants
Categories
Funding
- Respiratory Diseases Branch, Division of Microbiology and Infectious Diseases, NIAID
Ask authors/readers for more resources
Advances in the use of carbohydrates as vaccine candidates for the prevention of infectious and malignant diseases was the topic for a meeting in Rockville, MD, sponsored by the National Institute of Allergy and Infectious Diseases involving a diverse group of scientists. Participants included research scientists and clinicians from academia and industry, and representatives from the National Institutes of Health and US Food and Drug Administration. This workshop was the third in a series of meetings designed to address issues relating to the immune response to carbohydrate antigens and how this information is used in the development of vaccines. Participants also identified roadblocks, research opportunities and resource needs. The meeting was organized into sessions that focused on recent advances in the immune response to microbial and cancer carbohydrate antigens, glycomics, novel vaccine approaches, novel adjuvants and delivery systems.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available